Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125306401 | 12530640 | 1 | I | 20141029 | 20141215 | 20160706 | 20160706 | EXP | CN-009507513-1412CHN008437 | MERCK | 52.00 | YR | F | Y | 50.00000 | KG | 20160706 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125306401 | 12530640 | 1 | PS | EMEND | APREPITANT | 1 | Oral | 125 MG, ONCE, DAY 1 | 80 | MG | Y1248 | 21549 | 125 | MG | CAPSULE | 1X | |||
| 125306401 | 12530640 | 2 | SS | EMEND | APREPITANT | 1 | Oral | 80 MG, FOR DAY 2 AND 3 | 80 | MG | Y1248 | 21549 | 80 | MG | CAPSULE | QD | |||
| 125306401 | 12530640 | 3 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous drip | 120 MG/DAY 1, TREATMENT CYCLE 1/UNK, TREATMENT REGIMEN: TP | 0 | 120 | MG | INJECTION | |||||||
| 125306401 | 12530640 | 4 | SS | CISPLATIN. | CISPLATIN | 1 | Intravenous drip | 40 MG/D1-D3, TREATMENT CYCLE 1/UNK, TREATMENT REGIMEN: TP | 0 | 40 | MG | INJECTION | |||||||
| 125306401 | 12530640 | 5 | C | THYMOPENTIN | THYMOPENTIN | 1 | Intramuscular | 10 MG, QD | 90 | MG | U | 0 | 10 | MG | INJECTION | QD | |||
| 125306401 | 12530640 | 6 | C | AI DI ZHU SHE YE | 2 | Intravenous drip | 50 ML/CC, DAILY | 500 | ML | U | 0 | 50 | ML | INJECTION | QD | ||||
| 125306401 | 12530640 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Intravenous drip | 30 MG, QD | 90 | MG | U | 0 | 30 | MG | INJECTION | QD | |||
| 125306401 | 12530640 | 8 | C | reduced glutathione | 2 | Intravenous drip | 1.8 G, QD | 5.4000001 | G | U | 0 | 1.8 | G | INJECTION | QD | ||||
| 125306401 | 12530640 | 9 | C | LEVOCARNITINE. | LEVOCARNITINE | 1 | Intravenous drip | 3G, QD (STRENGTH 1G/5ML) | 9 | G | U | 0 | 3 | G | INJECTION | QD | |||
| 125306401 | 12530640 | 10 | C | TROPISETRON | TROPISETRON | 1 | Intravenous (not otherwise specified) | 5 MG, QD (STRENGTH 5MG/1ML) | 10 | MG | U | 0 | 5 | MG | INJECTION | QD | |||
| 125306401 | 12530640 | 11 | C | TROPISETRON | TROPISETRON | 1 | Intravenous (not otherwise specified) | 5 MG, QD (STRENGTH 5MG/1ML) | 10 | MG | U | 0 | 5 | MG | INJECTION | 1X | |||
| 125306401 | 12530640 | 12 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | TOTAL DAILY DOSE 8MG, FREQUENCY: BID | 3.75 | MG | U | 0 | TABLET | BID | |||||
| 125306401 | 12530640 | 13 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 3.75 MG, QD | 3.75 | MG | U | 0 | 3.75 | MG | TABLET | QD | |||
| 125306401 | 12530640 | 14 | C | VITAMINS (UNSPECIFIED) | VITAMINS | 1 | Intravenous drip | STRENGTH:1 BRANCH, QD | 3 | DF | U | 0 | 1 | DF | INJECTION | QD | |||
| 125306401 | 12530640 | 15 | C | VITAMINS (UNSPECIFIED) | VITAMINS | 1 | Intravenous drip | STRENGTH:1 BOTTLE, ONCE | 3 | DF | U | 0 | 1 | DF | INJECTION | 1X | |||
| 125306401 | 12530640 | 16 | C | VITAMIN C | ASCORBIC ACID | 1 | Intravenous drip | 2 G, QD (STRENGTH 0.5MG/2ML) | U | 0 | 2 | G | INJECTION | QD | |||||
| 125306401 | 12530640 | 17 | C | MANNITOL. | MANNITOL | 1 | Intravenous drip | 50 G, BID (STRENGTH 25G/125ML) | U | 0 | INJECTION | BID | |||||||
| 125306401 | 12530640 | 18 | C | DEXTROSE. | DEXTROSE | 1 | Intravenous drip | 200 ML/CC, QD | 2000 | ML | U | 0 | 200 | ML | INJECTION | QD | |||
| 125306401 | 12530640 | 19 | C | DEXTROSE. | DEXTROSE | 1 | 2000 | ML | U | 0 | INJECTION | ||||||||
| 125306401 | 12530640 | 20 | C | DEXTROSE. | DEXTROSE | 1 | Intravenous drip | 250 ML, QD | 750 | ML | U | 0 | 250 | ML | INJECTION | QD | |||
| 125306401 | 12530640 | 21 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 1.5 G, ONCE | 1.5 | G | U | 0 | 1.5 | G | INJECTION | 1X | |||
| 125306401 | 12530640 | 22 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Subcutaneous | 2 G, ONCE | 2 | G | U | 0 | 2 | G | INJECTION | 1X | |||
| 125306401 | 12530640 | 23 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Subcutaneous | 2 G, ONCE | 2 | G | U | 0 | 2 | G | INJECTION | 1X |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125306401 | 12530640 | 1 | Prophylaxis of nausea and vomiting |
| 125306401 | 12530640 | 3 | Chemotherapy |
| 125306401 | 12530640 | 4 | Chemotherapy |
| 125306401 | 12530640 | 5 | Immune enhancement therapy |
| 125306401 | 12530640 | 6 | Detoxification |
| 125306401 | 12530640 | 7 | Prophylaxis |
| 125306401 | 12530640 | 8 | Prophylaxis |
| 125306401 | 12530640 | 9 | Cardiovascular event prophylaxis |
| 125306401 | 12530640 | 10 | Prophylaxis of nausea and vomiting |
| 125306401 | 12530640 | 12 | Prophylaxis of nausea and vomiting |
| 125306401 | 12530640 | 14 | Vitamin supplementation |
| 125306401 | 12530640 | 16 | Vitamin supplementation |
| 125306401 | 12530640 | 17 | Diuretic therapy |
| 125306401 | 12530640 | 18 | Cardiovascular event prophylaxis |
| 125306401 | 12530640 | 19 | Cerebrovascular accident prophylaxis |
| 125306401 | 12530640 | 20 | Nutritional supplementation |
| 125306401 | 12530640 | 21 | Infusion |
| 125306401 | 12530640 | 22 | Infection prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125306401 | 12530640 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125306401 | 12530640 | Blood potassium decreased | |
| 125306401 | 12530640 | Blood sodium decreased | |
| 125306401 | 12530640 | Bone marrow failure | |
| 125306401 | 12530640 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125306401 | 12530640 | 1 | 20141025 | 20141025 | 0 | |
| 125306401 | 12530640 | 2 | 20141026 | 20141027 | 0 | |
| 125306401 | 12530640 | 3 | 20141025 | 20141025 | 0 | |
| 125306401 | 12530640 | 4 | 20141025 | 20141027 | 0 | |
| 125306401 | 12530640 | 5 | 20141011 | 20141019 | 0 | |
| 125306401 | 12530640 | 6 | 20141010 | 20141019 | 0 | |
| 125306401 | 12530640 | 7 | 20141025 | 20141027 | 0 | |
| 125306401 | 12530640 | 8 | 20141025 | 20141027 | 0 | |
| 125306401 | 12530640 | 9 | 20141025 | 20141027 | 0 | |
| 125306401 | 12530640 | 10 | 20141025 | 20141027 | 0 | |
| 125306401 | 12530640 | 11 | 20141029 | 20141029 | 0 | |
| 125306401 | 12530640 | 12 | 20141025 | 20141026 | 0 | |
| 125306401 | 12530640 | 13 | 20141027 | 20141028 | 0 | |
| 125306401 | 12530640 | 14 | 20141025 | 20141027 | 0 | |
| 125306401 | 12530640 | 15 | 20141029 | 20141029 | 0 | |
| 125306401 | 12530640 | 16 | 20141025 | 20141027 | 0 | |
| 125306401 | 12530640 | 17 | 20141025 | 20141027 | 0 | |
| 125306401 | 12530640 | 18 | 20141010 | 20141019 | 0 | |
| 125306401 | 12530640 | 20 | 20141029 | 20141031 | 0 | |
| 125306401 | 12530640 | 21 | 20141029 | 20141029 | 0 | |
| 125306401 | 12530640 | 22 | 20141029 | 20141029 | 0 | |
| 125306401 | 12530640 | 23 | 20141029 | 20141029 | 0 |